Hepatocellular Carcinoma Post Embolotherapy: Imaging Appearances and Pitfalls on Computed Tomography and Magnetic Resonance Imaging
Embolotherapies used in the treatment of hepatocellular carcinoma (HCC) include bland embolization, conventional transarterial chemoembolization (cTACE) using ethiodol as a carrier, TACE with drug-eluting beads and super absorbent polymer microspheres (DEB-TACE), and selective internal radiation therapy (SIRT). Successfully treated HCC lesions undergo coagulation necrosis, and appear as nonenhancing hypoattenuating or hypointense lesions in the embolized region on computed tomography (CT) and magnetic resonance.
Source: Canadian Association of Radiologists Journal - Category: Radiology Authors: Rita Y.W. Chiu, Wan W. Yap, Roshni Patel, David Liu, Darren Klass, Alison C. Harris Tags: Abdominal Imaging / Imagerie abdominale Source Type: research
More News: Brachytherapy | Cancer & Oncology | Carcinoma | CT Scan | Hepatocellular Carcinoma | Liver Cancer | MRI Scan | Radiation Therapy | Radiology